Insider trade

Officer sold ~$1.63M of DGX shares in the open market

Traded Jun 4, 2026 · Filed Jun 8, 2026

~$1.63M
Reported value · 8,147 sh @ $200.00: 14K
Holds after · shares reported: +17.8%
stock since the trade · S&P 500 +0.9%, $196.12 → $231.09 on Oct 1

Why it stands out

Quest Diagnostics's SVP, Clinical Solutions sold $1.63M of Quest Diagnostics shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jun 4, 2026
Reporting period: Not applicable
Filed with the SEC: Jun 8, 2026

Officer$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,629,400

Shares × reported transaction price

Timing vs results

44 days after results of Apr 21, 2026, 49 days before results of Jul 23, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $196.12 on Jun 4, 2026, 18% above its 52-week low and 7% below its high, after a 4% drop over the previous 30 trading days

52-week range $166.42 (Jul 15, 2025) to $211.91 (Feb 27, 2026), 65% of the way up, from 251 adjusted closes. 30 trading days earlier: $204.00 on Apr 22, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	-1.7%	+1.8%	-3.5%
30 days	+1.7%	+2.0%	-0.3%
90 days	+15.1%	+3.9%	+11.2%

Past results only. Not a forecast.

Source receipt

Record ID: 0001022079-26-000053
Filed / recorded: Jun 8, 2026, 8:32 PM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: QUEST DIAGNOSTICS INC
Issuer CIK: 1022079
Ticker: DGX
Reporting person: Karthik Kuppusamy
Relationship: Officer
Officer title: SVP, Clinical Solutions
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Jun 4, 2026
Transaction code: S
Shares / units: 8,147
Price per share: $200.00
Acquired / disposed: Disposed (D)
Shares owned after: 13,510
Ownership form: Direct
Amendment: No

Footnotes from the filing

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.